Notice on the reported suspected adverse reactions to the Tetanus Vaccine, Institute of Immunology d.d. in Bosnia & Herzegovina
The Agency for Medicinal Products and Medical Devices (HALMED) has been notified by the Agency for Medicinal Products and Medical Devices of Bosina & Herzegovina (ALMBiH) about five reported suspected adverse reactions after the use of the Tetanus Vaccine (adsorbed), Institute of Immunology, batch 78/3 with the expiry date by August 2015. The tetanus vaccine is indicated for stimulating the active immunity against tetanus.
The Agency for Medicinal Products and Medical Devices B&H has concluded that the benefits/risks ratio for this vaccine remains positive. According to HALMED’s data, the Tetanus Vaccine manufactured by Institute of Immunology d.d., including this batch is not on the Croatian market.
More information is accessible under the link below.